Core Points - The company, Sanxia New Materials, announced the convening of its fourth temporary board meeting for 2025 on October 23, 2025, using a combination of in-person and electronic communication methods [2] - The board approved a proposal to adjust the members of the company's 12th Compensation and Assessment Committee [2]

Core Viewpoint - The company, Three Gorges New Materials (600293.SH), reported a significant decline in revenue and incurred a net loss in the third quarter of 2025 [2] Financial Performance - The company's revenue for the first three quarters was 897 million yuan, representing a year-on-year decrease of 27.29% [2] - The net profit attributable to shareholders of the listed company was a loss of 59.85 million yuan [2]

Group 1: Company Performance - Sanxia New Materials reported a revenue of approximately 897 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 27.29% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 59.85 million yuan [1] - The basic earnings per share showed a loss of 0.05 yuan [1] Group 2: Market Context - As of the report, the market capitalization of Sanxia New Materials is 4 billion yuan [2] - The Chinese innovative drug sector has seen significant overseas licensing sales, totaling 80 billion US dollars this year [2] - There is a contrast in the biopharmaceutical secondary market being active while the primary market is experiencing a fundraising slowdown [2]

Group 1 - The core point of the news is that Sanxia New Materials (SH 600293) held its fourth temporary board meeting for 2025 on October 23, 2025, to discuss adjustments to the remuneration and assessment committee members [1] - For the year 2024, the revenue composition of Sanxia New Materials is reported to be 98.55% from glass manufacturing and processing, with other businesses contributing 1.45% [1] - As of the report date, the market capitalization of Sanxia New Materials is 4 billion yuan [2]

因公司董事会结构和成员调整，为保证董事会专门委员会正 常有序开展工作，根据《中华人民共和国公司法》《公司章程》 及董事会各专门委员会实施细则等有关规定，公司董事会拟增补 职工董事许建国先生为第十二届董事会薪酬与考核委员会成员。 调整后公司第十二届董事会各专门委员会成员组成情况如下： | 委员会名称 | 调整后委员会成员 | | --- | --- | | 战略委员会 | 谢普乐（召集人）、刘正斌、汪艳妮、陶海征、周扬 | | 审计委员会 | 王小宁（召集人）、卢以品、潘琳 | | 提名委员会 | 陶海征（召集人）、谢普乐、王小宁 | | 薪酬与考核委员会 | 卢以品（召集人）、王小宁、陶海征、汪艳妮、许建国 | 上述专门委员会的调整自本次董事会审议通过之日起生效， 任期至第十二届董事会届满之日止。调整后的薪酬与考核委员会 1 证券代码：600293 证券简称：三峡新材 公告编号：2025-040 湖北三峡新型建材股份有限公司关于调整 第十二届董事会薪酬与考核委员会委员的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性 和完整性承担法律责任。 湖 ...

证券代码：600293 证券简称：三峡新材 公告编号：2025-042 湖北三峡新型建材股份有限公司 关于冷修中的固定资产公开挂牌处置的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和 完整性承担法律责任。 重要内容提示： 一、交易概述 （一）本次交易的基本情况 根据工作安排，现需对浮法一线机器设备进行拆除，结合设 备管理整理的机器设备清单，本次处置范围主要涉及七个部分， 分别为联合机械设备、原料机械设备、水汽机械设备、联合机械 电气自控设备、原料电气自控设备、水汽电气自控设备、变电部 1 湖北三峡新型建材股份有限公司（以下简称"公司"）拟 通过武汉光谷联合产权交易所以公开挂牌方式处置控股 子公司当阳正达材料科技有限公司（以下简称"浮法一线"） 冷修中的部分固定资产。 本次交易不构成关联交易，不构成重大资产重组。 本次交易已经公司董事会 2025 年第四次临时会议审议通 过，尚需提交公司股东会审议。 本次资产处置通过公开挂牌方式交易，尚无明确受让方， 最终交易时间、交易价格存在不确定性。 分设备（以下简称"本次资产处置"）。为确保资产处置合规 ...

关于部分固定资产会计估计变更的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性 和完整性承担法律责任。 证券代码：600293 证券简称：三峡新材 公告编号：2025-041 湖北三峡新型建材股份有限公司 重要内容提示： 根据《企业会计准则第 28 号——会计政策、会计估计变 更和差错更正》的相关规定，湖北三峡新型建材股份有限公司（以 下简称"公司"）本次会计估计变更拟采用未来适用法进行会计处 理，无需进行追溯调整，不会对公司以前年度的财务状况和经营 成果产生重大影响。 本次会计估计变更自 2025 年 10 月 1 日起实施。 本次会计估计变更无需提交公司股东会审议。 一、本次会计估计变更概述 （一）会计估计变更的内容概述 根据《企业会计准则》相关规定及公司固定资产的实际使用 情况，为更加客观真实反映公司经营情况，在遵循会计核算谨慎 性原则的基础上，拟对控股子公司新疆普耀新型建材有限公司生 产线（以下简称"新疆产线"）部分资产折旧年限及残值率进行 相应调整。 1 （二）履行的审批程序 公司于 2025 年 10 月 23 日召开了董事会 20 ...

证券代码：600293 证券简称：三峡新材 公告编号：2025-043 湖北三峡新型建材股份有限公司 关于召开2025年第三次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东会类型和届次 2025年第三次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 11 月 10 日 10 点 30 分 召开地点：湖北省宜昌市南玻路 A5 栋湖北三峡新材科技有限公司二楼会议 室 (五)网络投票的系统、起止日期和投票时间。 股东会召开日期：2025年11月10日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 至2025 年 11 月 10 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过 互联网投票 ...

证券代码：600293 证券简称：三峡新材 公告编号：2025-039 湖北三峡新型建材股份有限公司 董事会 2025 年第四次临时会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性 和完整性承担法律责任。 一、董事会会议召开情况 湖北三峡新型建材股份有限公司（以下简称"公司"）董事 会2025年第四次临时会议于2025年10月20日以邮件、微信、电话 等电子通信方式发出会议通知，于2025年10月23日在湖北省宜昌 市南玻路A5栋湖北三峡新材科技有限公司二楼会议室以现场结 合电子通信方式召开及表决。会议应出席董事9人，实际出席董 事9人，会议由董事长谢普乐先生召集并主持。本次会议的召开 符合有关法律、行政法规、部门规章、规范性文件和《公司章程》 的规定。 二、董事会会议审议情况 （一）会议审议通过了《关于公司〈2025 年第三季度报告〉 的议案》。 公司董事会认为：公司 2025 年第三季度报告的内容真实、 准确、完整，不存在虚假记载、误导性陈述或者重大遗漏。 公司第十二届董事会审计委员会 2025 年第六次会议已对本 议案中的财务报表 ...

Financial Performance - The company's operating revenue for the third quarter was ¥271,810,512.33, a decrease of 25.56% compared to the same period last year[4] - The total profit for the quarter was -¥33,066,093.07, representing a decline of 67.43% year-on-year[4] - The net profit attributable to shareholders was -¥32,860,872.11, down 75.56% from the previous year[4] - The net profit after deducting non-recurring gains and losses was -¥41,288,969.01, a decrease of 53.50% compared to the same period last year[4] - The basic earnings per share for the quarter was -¥0.03, a reduction of 50.00% year-on-year[4] - Total operating revenue for the first three quarters of 2025 was CNY 897.28 million, a decrease of 27.2% compared to CNY 1,234.01 million in the same period of 2024[17] - The net profit for the first three quarters of 2025 was a loss of CNY 58.05 million, compared to a profit of CNY 14.79 million in the same period of 2024[18] - The total comprehensive income for the first three quarters of 2025 was a loss of CNY 58.05 million, compared to a gain of CNY 14.79 million in 2024[18] - Basic and diluted earnings per share for the first three quarters of 2025 were both CNY -0.05, compared to CNY 0.01 in the same period of 2024[18] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,302,298,524.30, a decrease of 1.11% from the end of the previous year[6] - The company's current assets decreased to CNY 632,801,142.90 from CNY 731,590,823.23, representing a decline of approximately 13.5%[15] - The total liabilities of the company were CNY 1,476,660,474.08, slightly up from CNY 1,466,213,654.44, indicating a marginal increase of about 0.2%[16] - The company's short-term borrowings rose to CNY 358,716,619.05 from CNY 328,930,302.95, an increase of approximately 9.1%[16] - Total assets as of September 30, 2025, were CNY 3,090,323,290.45, down from CNY 3,215,704,231.43 at the end of 2024[21] - Total liabilities as of September 30, 2025, were CNY 1,348,732,867.54, a decrease from CNY 1,445,739,299.49 at the end of 2024[22] - The company’s total equity as of September 30, 2025, was CNY 1,741,590,422.91, down from CNY 1,769,964,931.94 at the end of 2024[22] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥81,262,129.11, a decline of 280.58% year-on-year[4] - Cash flow from operating activities showed a net outflow of CNY 81.26 million, worsening from a net outflow of CNY 21.35 million in the same period last year[19] - Cash flow from investing activities resulted in a net outflow of CNY 18.99 million, compared to a net outflow of CNY 57.79 million in 2024[20] - The net cash flow from operating activities for the first three quarters of 2025 was CNY 43,333,191.58, compared to a net outflow of CNY 48,735,549.86 in the first three quarters of 2024[26] - The net cash flow from financing activities for the first three quarters of 2025 was -CNY 24,397,401.33, an improvement from -CNY 84,590,424.55 in the first three quarters of 2024[26] - The company reported a net cash outflow of CNY 17,214,083.09 in cash and cash equivalents for the first three quarters of 2025, an improvement from -CNY 171,087,366.68 in the same period of 2024[26] Research and Development - Research and development expenses increased to CNY 66.43 million, up 16.5% from CNY 56.85 million in the previous year[17] - Research and development expenses for the first three quarters of 2025 were CNY 64,018,279.74, an increase from CNY 55,264,801.38 in the same period of 2024[24] Shareholder Information - There are no significant changes in the top ten shareholders or their shareholding structure reported[13] - The company has not disclosed any significant new product developments or market expansion strategies during the reporting period[14] Other Financial Metrics - The decline in revenue and profits was primarily attributed to a decrease in product sales prices and operating margins[9] - The company reported non-recurring gains of ¥8,428,096.90 for the quarter, down from ¥62,062,046.22 year-to-date[8] - The company reported an increase in accounts receivable to CNY 293,377,461.08 as of September 30, 2025, compared to CNY 270,346,693.36 at the end of 2024[21] - Cash and cash equivalents dropped significantly from CNY 363,906,189.12 to CNY 191,452,119.56, a decrease of about 47.4%[15] - The cash and cash equivalents at the end of the period increased to CNY 175.91 million, up from CNY 143.61 million at the end of the same period last year[20] - The total cash and cash equivalents at the end of the first three quarters of 2025 was CNY 97,946,781.38, compared to CNY 33,821,153.52 at the end of the same period in 2024[26] - The company has not adopted new accounting standards or interpretations that would affect the financial statements for the year[27]